What is ALNY's EasyStocksAI score?

Alnylam Pharmaceuticals Inc. (ALNY) scores 40 out of 100 on EasyStocksAI's Graham-inspired scoring system. Breakdown: Total Shareholder Yield: 0/25, Return Consistency: 0/25, Return Growth: 0/25, Payment Regularity: 0/25, Revenue Growth: 10/25, Earnings Growth: 0/25, Margin Trend: 2/25, Capital Efficiency: 3/25, P/E vs Sector: 0/25, Graham Ratio Trend: 0/25, Price Stability: 0/25, Earnings Yield: 0/25, 10Y SPY Outperformance: 8/25, 10Y Sector Outperformance: 9/25, Crisis Resilience: 11/25.

Does ALNY pay dividends?

Alnylam Pharmaceuticals Inc. does not currently pay a regular dividend.

Alnylam Pharmaceuticals Inc.'s Graham Number is 17.64. The current price of 317.23 is above the Graham Number.

How does ALNY compare to the Health Care sector?

Alnylam Pharmaceuticals Inc. has a P/E ratio of 135.09 in the Health Care sector.

insights

EasyStocksAI

ALN

ALNY

Alnylam Pharmaceuticals Inc.

$317.23 arrow_downward $3.20 (1.00%)

AI Score

N/A

Loading chart…

Loading chart...

analytics Financial Highlights

P/E Ratio 135.09

Dividend Yield 0.00%

Graham Number 17.64

Market Cap $42.7B

Div. Increase Years 0

Continuous Years 0

Crises Survived 3

speed Performance Benchmarks

vs S&P 500 (10Y) +49.03%

vs Sector (10Y) +250.56%

speed Market Sentiment

Extreme Fear

OVERALL MARKET CONFIDENCE

show_chart Trend Analysis

Primary Trend

▼ Downtrend

Secondary Trend Bearish

Warning Price rose above 20-day MA

MA 20

325.91

MA 50

346.84

MA 200

392.10

analytics Sector Comparison (Health Care)

P/E Ratio —

Graham Ratio —

Track ALNY and 1,000+ stocks for free

Get scores, alerts, and portfolio tracking — no credit card required.

Start Free →